<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03249857</url>
  </required_header>
  <id_info>
    <org_study_id>1708056</org_study_id>
    <secondary_id>2017-A00917-46</secondary_id>
    <nct_id>NCT03249857</nct_id>
  </id_info>
  <brief_title>Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.</brief_title>
  <official_title>Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based in an embodied approach of cognition, several studies have highlighted a direct link
      between perception of an object or an emotion and the associated motor responses. This study
      investigated in patients suffering from bipolar affective disorders whether the perception of
      emotional words involves an automatic sensorimotor simulation of approach and avoidance
      behaviors, and whether the perception of an object involves an automatic sensorimotor
      simulation of object prehension (affordance). We hypothesize that, in this pathology, low
      level (sensorimotor) cognitive processes are preserved whereas high-level (attentional) are
      altered. 20 patients suffering from bipolar affective disorders and 20 healthy controls will
      be recruited. The main objective is the emergence of sensorimotor compatibility effects in
      approach-avoidance task with emotional stimuli (gain between compatible vs incompatible
      conditions).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 26, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>response time for avoidance and affordance task</measure>
    <time_frame>Months 24</time_frame>
    <description>Comparison of response time for avoidance and affordance task between patients and healthy volunteers.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>response time for affordance task</measure>
    <time_frame>Months 24</time_frame>
    <description>Comparison of response time for affordance task between patients and healthy volunteers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlations with age at onset of the disease, the number of thymic decompensations and the existence of psychotic symptoms</measure>
    <time_frame>Months 24</time_frame>
    <description>These informations were collected of the medical file.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>response time and cognitive tests</measure>
    <time_frame>Months 24</time_frame>
    <description>Correlation between response time and cognitive tests of patients and healthy volunteers.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Bipolar Affective Disorder</condition>
  <arm_group>
    <arm_group_label>patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients suffering bipolar affective disorders and who will perform cognitive tasks + IQ + MINI + experimental task</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy volunteers (Control group) who will perform cognitive tasks + experimental task</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cognitive tasks + IQ + MINI</intervention_name>
    <description>Patients will perform different tasks:
cognitive tasks : reaction time (Alert TEA, Zimmermann and Fimm, 2005) + Edinburgh laterality questionnaire (Oldfield,1971) + hamilton and young's scale (Tohen et al., 2009) + Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 2005) + experimental task (approach/ avoidance and affordance task).
Intelligence Quotient (IQ) test (PM38, Raven, 1960)
Mini International Neuropsychiatric Interview (MINI, Van Vliet et al., 2006)</description>
    <arm_group_label>patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cognitive tasks</intervention_name>
    <description>Healthy volunteers will perform only the cognitive tasks = reaction time alert TEA, Zimmermann and Fimm, 2005 + Edinburgh laterality questionnaire (Oldfield, 1971) + experimental task (approach/ avoidance and affordance task).</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For patients:

          -  Affiliated or entitled to a social security

          -  Aged between 18 and 55

          -  Patients of both sexes suffering from bipolar disorders (DSM V criteria) whatever the
             subtype

          -  Stabilized from a point of view clinical and therapeutic

          -  Euthymic (score &lt;7 at the Hamilton scale, and score &lt;8 at Young's scale)

          -  Must have given their informed consent before their participation in the study

          -  Be right-handed (score&gt; 14 on the laterality scale)

        For control group:

          -  Affiliated or entitled to a social security

          -  Must have given their informed consent before their participation in the study

          -  Be right-handed (score&gt; 14 on the lateral scale)

          -  Aged 18 to 55 matched by age (± 5 years), sex, and on the study level of patients
             (years of schooling after primary school ± 2 years)

        Exclusion Criteria:

        For patients:

          -  Thymic acute decompensation

          -  Hamilton scale &gt; 8, Young's scale &gt; 9

          -  Montreal Cognitive Assessment (MOCA) &lt;26

          -  History neurological pathology with cerebral impairment or serious somatic disease

          -  Disorders related to the use of a psychoactive substance, as defined by the DSM-V
             (abuse, dependence or withdrawal) within 6 months.

          -  IQ &lt; 70

          -  History of head trauma

        For control group:

          -  History of head trauma

          -  Neurological pathology with cerebral impairment or serious somatic disease

          -  Psychotropic treatment

          -  Disorders related to the use of a psychoactive substance, as defined by the DSM-V
             (abuse, dependence or withdrawal)

          -  IQ &lt; 70
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine MASSOUBRE, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU SAINT-ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne GROSSELIN, neuropychologue</last_name>
    <phone>(33)477127743</phone>
    <email>anne.grosselin@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne GROSSELIN, neuropychologue</last_name>
    <email>anne.grosselin@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>St Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine MASSOUBRE, MD</last_name>
      <phone>(0)477127962</phone>
      <phone_ext>+33</phone_ext>
      <email>catherine.massoubre@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine MASSOUBRE, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tania FERRAGUT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amandine BORDRON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Christine OUVRY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie VIALLON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephane BOYER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Torrance SIGAUD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélia GAY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2017</study_first_submitted>
  <study_first_submitted_qc>August 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2017</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bipolar affective disorders</keyword>
  <keyword>Cognition</keyword>
  <keyword>Emotion</keyword>
  <keyword>Embodiment</keyword>
  <keyword>Sensorimotor</keyword>
  <keyword>Simulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Mood Disorders</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Genetic Diseases, X-Linked</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

